The role of diffusion-weighted MRI and 18F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: A systematic review

Radiotherapy and Oncology

Volumn 113, Issue 2, 2014, Pages 158-165

  Joye, Ines ^a,b   Deroose, Christophe M ^a   Vandecaveye, Vincent ^a   Haustermans, Karin ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

18F FDG PET CT; Diffusion weighted MRI; Pathological complete response; Radiochemotherapy; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EMBASE; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT ACCURACY; MEDLINE; PREDICTIVE VALUE; PUBLICATION; RECTUM CANCER; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; RECTAL NEOPLASMS; SCINTISCANNING; TREATMENT OUTCOME;

CHEMORADIOTHERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84915813432     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.11.026     Document Type: Review

References (70)

1. R. Sauer, H. Becker, and W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
2. J.F. Bosset, L. Collette, and G. Calais Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 2006 1114 1123
3. J.K. MacFarlane, R.D. Ryall, and R.J. Heald Mesorectal excision for rectal cancer Lancet 341 1993 457 460
4. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
5. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674
6. F.M. Vecchio, V. Valentini, and B.D. Minsky The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer Int J Radiat Oncol Biol Phys 62 2005 752 760
7. A Habr-Gama, Perez, and W Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 2004 711 717 discussion 717-8
8. M. Maas, R.G. Beets-Tan, and D.M. Lambregts Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
9. R.S. Dalton, R. Velineni, and M.E. Osborne A single-centre experience of chemoradiotherapy for rectal cancer: is there potential for nonoperative management? Colorectal Dis 14 2012 567 571
10. K.C. Peeters, C.J. van de Velde, and J.W. Leer Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study J Clin Oncol 23 2005 6199 6206
11. F.H. Remzi, V.W. Fazio, and E. Gorgun Quality of life, functional outcome, and complications of coloplasty pouch after low anterior resection Dis Colon Rectum 48 2005 735 743
12. C.A. Sartori, A. Sartori, S. Vigna, R. Occhipinti, and G.L. Baiocchi Urinary and sexual disorders after laparoscopic TME for rectal cancer in males J Gastrointest Surg 15 2011 637 643
13. R.S. Zhao, H. Wang, Z.Y. Zhou, Q. Zhou, and M.W. Mulholland Restaging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis Dis Colon Rectum 57 2014 388 395
14. A.M. Hanly, E.M. Ryan, and A.C. Rogers Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant (MERRION) Therapy Ann Surg 259 2014 723 727
15. J.W. Huh, Y.A. Park, E.J. Jung, K.Y. Lee, and S.K. Sohn Accuracy of endorectal ultrasonography and computed tomography for restaging rectal cancer after preoperative chemoradiation J Am Coll Surg 207 2008 7 12
16. J.H. Lee, H.S. Jang, and J.G. Kim Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02 Radiother Oncol 113 2014 18 23
17. D.M. Patterson, A.R. Padhani, and D.J. Collins Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy Nat Clin Pract Oncol 5 2008 220 233
18. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635
19. T. Seierstad, K. Røe, and D.R. Olsen Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model Radiother Oncol 85 2007 187 194
20. M. Schelling, N. Avril, and J. Nährig Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer J Clin Oncol 18 2000 1689 1695
21. H.A. Wieder, B.L. Brücher, and F. Zimmermann Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment J Clin Oncol 22 2004 900 908
22. C. Bokemeyer, C. Kollmannsberger, and K. Oechsle Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET Br J Cancer 86 2002 506 511
23. F. Macbeth, and J. Overgaard Expert reviews, systematic reviews and meta-analyses Radiother Oncol 64 2002 233 234
24. P. Whiting, A.W. Rutjes, J.B. Reitsma, P.M. Bossuyt, and J. Kleijnen The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
25. M. Lambrecht, V. Vandecaveye, and F. De Keyzer Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results Int J Radiat Oncol Biol Phys 82 2012 863 870
26. M. Lambrecht, C. Deroose, and S. Roels The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer Acta Oncol 49 2010 956 963
27. M. Intven, O. Reerink, and M.E. Philippens Diffusion-weighted MRI in locally advanced rectal cancer: pathological response prediction after neo-adjuvant radiochemotherapy Strahlenther Onkol 189 2013 117 122
28. S.H. Kim, J.Y. Lee, J.M. Lee, J.K. Han, and B.I. Choi Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer Eur Radiol 21 2011 987 995
29. L. Curvo-Semedo, D.M. Lambregts, and M. Maas Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy-conventional MR volumetry versus diffusion-weighted MR imaging Radiology 260 2011 734 743
30. G. Engin, R. Sharifov, and Z. Güral Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer? Diagn Interv Radiol 18 2012 574 581
31. E.M. Lee, Y.S. Hong, and K.P. Kim Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer Cancer Sci 104 2013 111 115
32. D Genovesi, A Filippone, and G Ausili Cèfare Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study Eur J Surg Oncol 39 2013 1071 1078
33. H.I. Ha, A.Y. Kim, C.S. Yu, S.H. Park, and H.K. Ha Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy Eur Radiol 23 2013 3345 3353
34. DM Lambregts, SX Rao, and S Sassen MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a bi-institutional validation study Ann Surg 2014 Sep 10
35. S.H. Kim, J.M. Lee, and S.H. Hong Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy Radiology 253 2009 116 125
36. I. Song, S.H. Kim, S.J. Lee, J.Y. Choi, M.J. Kim, and H. Rhim Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging Br J Radiol 85 2012 577 586
37. D.M. Lambregts, V. Vandecaveye, and B. Barbaro Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study Ann Surg Oncol 18 2011 2224 2231
38. S. Sassen, M. de Booij, and M. Sosef Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol 23 2013 3440 3449
39. RO Perez, A Habr-Gama, and GP São Julião Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging Tech Coloproctol 18 2014 699 708
40. A. Konski, T. Li, and E. Sigurdson Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation Int J Radiat Oncol Biol Phys 74 2009 55 59
41. C. Capirci, D. Rubello, and F. Pasini The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery Int J Radiat Oncol Biol Phys 74 2009 1461 1469
42. P. Palma, R. Conde-Muíño, and A. Rodríguez-Fernández The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer Radiat Oncol 5 2010 119
43. A.A. Martoni, F. Di Fabio, and C. Pinto Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer Ann Oncol 22 2011 650 656
44. H. Hur, N.K. Kim, and M. Yun 18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer J Surg Oncol 103 2011 17 24
45. S. Shanmugan, R. Arrongoiz, and J.R. Nitzorkski Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT Ann Surg Oncol 19 2012 2178 2185
46. 18F-FDG PET-CT imaging. A prospective clinical study Radiat Oncol 7 2012 124
47. J.G. Guillem, J.A. Ruby, and T. Leibold Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study Ann Surg 258 2013 289 295
48. J.W. Kim, H.C. Kim, and J.W. Park Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy Int J Colorectal Dis 28 2013 1217 1224
49. S.J. Lee, J.G. Kim, and S.W. Lee Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy Cancer Chemother Pharmacol 71 2013 1201 1207
50. C. Bampo, A. Alessi, and S. Fantini Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation? Oncology 84 2013 191 199
51. R.G. van Stiphout, G. Lammering, and J. Buijsen Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging Radiother Oncol 98 2011 126 133
52. W. Sun, J. Xu, W. Hu, Z. Zhang, and W. Shen The role of sequential 18(F)-FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer Colorectal Dis 15 2013 e231 e238
53. JW Huh, SY Kwon, JH Lee, and HR Kim Comparison of restaging accuracy of repeat FDG-PET/CT with pelvic MRI after preoperative chemoradiation in patients with rectal cancer J Cancer Res Clin Oncol 2014 Sep 3 Epub ahead of print
54. C. Capirci, D. Rubello, and F. Chierchetti Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET Biomed Pharmacother 58 2004 451 457
55. V. Kalff, C. Duong, E.G. Drummond, J.P. Matthews, and R.J. Hicks Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery J Nucl Med 47 2006 14 22
56. R.F. Vliegen, R.G. Beets-Tan, and B. Vanhauten Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer? Strahlenther Onkol 184 2008 457 464
57. C. Kristiansen, A. Loft, and A.K. Berthelsen PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer Dis Colon Rectum 51 2008 21 25
58. V. Kalff, R. Ware, A. Heriot, M. Chao, E. Drummond, and R.J. Hicks Radiation changes do not interfere with postchemoradiation restaging of patients with rectal cancer by FDG PET/CT before curative surgical therapy Int J Radiat Oncol Biol Phys 74 2009 60 66
59. 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer World J Surg 33 2009 2688 2694
60. D. Mak, D.L. Joon, and M. Chao The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer Radiother Oncol 97 2010 205 211
61. 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer Eur J Nucl Med Mol Imaging 40 2013 91 97
62. JP Burbach, AM den Harder, M Intven, M van Vulpen, HM Verkooijen, and O Reerink Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: A systematic review and meta-analysis Radiother Oncol 113 2014 1 9
63. Y. Mardor, Y. Roth, and A. Ochershvilli Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI Neoplasia 6 2004 136 142
64. D.M. Koh, E. Scurr, and D. Collins Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients AJR Am J Roentgenol 188 2007 1001 1008
65. L. Harrison, and K. Blackwell Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9 2004 31 40
66. J. Buijsen, R.G. van Stiphout, P.P. Menheere, G. Lammering, and P. Lambin Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer Radiother Oncol 111 2014 237 242
67. H. Hur, N.K. Kim, and B.S. Min Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer? Dis Colon Rectum 57 2014 592 601
68. Y. Edden, S.D. Wexner, and M. Berho The use of molecular markers as a method to predict the response to neoadjuvant therapy for advanced stage rectal adenocarcinoma Colorectal Dis 14 2012 555 561
69. H. Tulchinsky, E. Shmueli, A. Figer, J.M. Klausner, and M. Rabau An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol 15 2008 2661 2667
70. A.M. Wolthuis, F. Penninckx, and K. Haustermans Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome Ann Surg Oncol 19 2012 2833 2841